Copyright Reports & Markets. All rights reserved.

Global Point of Care Testing for Infectious Disease Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Point of Care Testing for Infectious Disease Market Overview

    • 1.1 Product Overview and Scope of Point of Care Testing for Infectious Disease
    • 1.2 Classification of Point of Care Testing for Infectious Disease by Type
      • 1.2.1 Global Point of Care Testing for Infectious Disease Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Type in 2019
      • 1.2.3 Type I
      • 1.2.4 Type II
    • 1.3 Global Point of Care Testing for Infectious Disease Market by Application
      • 1.3.1 Overview: Global Point of Care Testing for Infectious Disease Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Glucose
      • 1.3.3 Lipids
      • 1.3.4 HCV
      • 1.3.5 HIV
      • 1.3.6 Influenza
      • 1.3.7 Urinalysis
      • 1.3.8 Other
    • 1.4 Global Point of Care Testing for Infectious Disease Market by Regions
      • 1.4.1 Global Point of Care Testing for Infectious Disease Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Point of Care Testing for Infectious Disease (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point of Care Testing for Infectious Disease Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Abbott
      • 2.1.1 Abbott Details
      • 2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Abbott SWOT Analysis
      • 2.1.4 Abbott Product and Services
      • 2.1.5 Abbott Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 PTS Diagnostics
      • 2.2.1 PTS Diagnostics Details
      • 2.2.2 PTS Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 PTS Diagnostics SWOT Analysis
      • 2.2.4 PTS Diagnostics Product and Services
      • 2.2.5 PTS Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Danaher
      • 2.3.1 Danaher Details
      • 2.3.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Danaher SWOT Analysis
      • 2.3.4 Danaher Product and Services
      • 2.3.5 Danaher Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Roche
      • 2.4.1 Roche Details
      • 2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Roche SWOT Analysis
      • 2.4.4 Roche Product and Services
      • 2.4.5 Roche Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Instrumentation Laboratory
      • 2.5.1 Instrumentation Laboratory Details
      • 2.5.2 Instrumentation Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Instrumentation Laboratory SWOT Analysis
      • 2.5.4 Instrumentation Laboratory Product and Services
      • 2.5.5 Instrumentation Laboratory Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Siemens
      • 2.6.1 Siemens Details
      • 2.6.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Siemens SWOT Analysis
      • 2.6.4 Siemens Product and Services
      • 2.6.5 Siemens Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Sekisui Diagnostics
      • 2.7.1 Sekisui Diagnostics Details
      • 2.7.2 Sekisui Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Sekisui Diagnostics SWOT Analysis
      • 2.7.4 Sekisui Diagnostics Product and Services
      • 2.7.5 Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Johnson & Johnson
      • 2.8.1 Johnson & Johnson Details
      • 2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Johnson & Johnson SWOT Analysis
      • 2.8.4 Johnson & Johnson Product and Services
      • 2.8.5 Johnson & Johnson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Becton, Dickinson
      • 2.9.1 Becton, Dickinson Details
      • 2.9.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Becton, Dickinson SWOT Analysis
      • 2.9.4 Becton, Dickinson Product and Services
      • 2.9.5 Becton, Dickinson Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Quidel (US), Chembio
      • 2.10.1 Quidel (US), Chembio Details
      • 2.10.2 Quidel (US), Chembio Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Quidel (US), Chembio SWOT Analysis
      • 2.10.4 Quidel (US), Chembio Product and Services
      • 2.10.5 Quidel (US), Chembio Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Nova
      • 2.11.1 Nova Details
      • 2.11.2 Nova Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Nova SWOT Analysis
      • 2.11.4 Nova Product and Services
      • 2.11.5 Nova Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Trinity Biotech
      • 2.12.1 Trinity Biotech Details
      • 2.12.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Trinity Biotech SWOT Analysis
      • 2.12.4 Trinity Biotech Product and Services
      • 2.12.5 Trinity Biotech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 EKF Diagnostics
      • 2.13.1 EKF Diagnostics Details
      • 2.13.2 EKF Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 EKF Diagnostics SWOT Analysis
      • 2.13.4 EKF Diagnostics Product and Services
      • 2.13.5 EKF Diagnostics Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 AccuBioTech
      • 2.14.1 AccuBioTech Details
      • 2.14.2 AccuBioTech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 AccuBioTech SWOT Analysis
      • 2.14.4 AccuBioTech Product and Services
      • 2.14.5 AccuBioTech Point of Care Testing for Infectious Disease Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Point of Care Testing for Infectious Disease Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Point of Care Testing for Infectious Disease Players Market Share
      • 3.2.2 Top 10 Point of Care Testing for Infectious Disease Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Point of Care Testing for Infectious Disease Revenue and Market Share by Regions
    • 4.2 North America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 4.5 South America Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    5 North America Point of Care Testing for Infectious Disease Revenue by Countries

    • 5.1 North America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)
    • 5.2 USA Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    6 Europe Point of Care Testing for Infectious Disease Revenue by Countries

    • 6.1 Europe Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)
    • 6.2 Germany Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 6.3 UK Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 6.4 France Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Countries

    • 7.1 Asia-Pacific Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)
    • 7.2 China Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 7.5 India Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    8 South America Point of Care Testing for Infectious Disease Revenue by Countries

    • 8.1 South America Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)
    • 8.2 Brazil Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Point of Care Testing for Infectious Disease by Countries

    • 9.1 Middle East & Africa Point of Care Testing for Infectious Disease Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Point of Care Testing for Infectious Disease Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Point of Care Testing for Infectious Disease Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Point of Care Testing for Infectious Disease Market Forecast by Type (2019-2024)
    • 10.3 Type I Revenue Growth Rate (2015-2025)
    • 10.4 Type II Revenue Growth Rate (2015-2025)

    11 Global Point of Care Testing for Infectious Disease Market Segment by Application

    • 11.1 Global Point of Care Testing for Infectious Disease Revenue Market Share by Application (2015-2020)
    • 11.2 Point of Care Testing for Infectious Disease Market Forecast by Application (2019-2024)
    • 11.3 Glucose Revenue Growth (2015-2020)
    • 11.4 Lipids Revenue Growth (2015-2020)
    • 11.5 HCV Revenue Growth (2015-2020)
    • 11.6 HIV Revenue Growth (2015-2020)
    • 11.7 Influenza Revenue Growth (2015-2020)
    • 11.8 Urinalysis Revenue Growth (2015-2020)
    • 11.9 Other Revenue Growth (2015-2020)

    12 Global Point of Care Testing for Infectious Disease Market Size Forecast (2021-2025)

    • 12.1 Global Point of Care Testing for Infectious Disease Market Size Forecast (2021-2025)
    • 12.2 Global Point of Care Testing for Infectious Disease Market Forecast by Regions (2021-2025)
    • 12.3 North America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)
    • 12.4 Europe Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)
    • 12.6 South America Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Point of Care Testing for Infectious Disease Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

      The Point of Care Testing for Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Point of Care Testing for Infectious Disease market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Point of Care Testing for Infectious Disease market has been segmented into:
      Type I
      Type II

      By Application, Point of Care Testing for Infectious Disease has been segmented into:
      Glucose
      Lipids
      HCV
      HIV
      Influenza
      Urinalysis
      Other

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Point of Care Testing for Infectious Disease market presented in the report. This section sheds light on the sales growth of different regional and country-level Point of Care Testing for Infectious Disease markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point of Care Testing for Infectious Disease market.

      The report offers in-depth assessment of the growth and other aspects of the Point of Care Testing for Infectious Disease market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Competitive Landscape and Point of Care Testing for Infectious Disease Market Share Analysis
      Point of Care Testing for Infectious Disease competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Point of Care Testing for Infectious Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point of Care Testing for Infectious Disease sales, revenue and market share for each player covered in this report.

      The major players covered in Point of Care Testing for Infectious Disease are:
      Abbott
      PTS Diagnostics
      Danaher
      Roche
      Instrumentation Laboratory
      Siemens
      Sekisui Diagnostics
      Johnson & Johnson
      Becton, Dickinson
      Quidel (US), Chembio
      Nova
      Trinity Biotech
      EKF Diagnostics
      AccuBioTech

      Buy now